Connect with us
-->

Covid19

COVID-19 Vaccine Targetted To Kill People – Bello

APC’s 2023 Presidential Aspirant Warns

Published

on

Yahaya Bello Won't take COVID-19 vaccine

Governor Yahaya Bello, the only publicly declared presidential aspirant on the platform of the All Progressives Congress, APC has warned that the COVID-19 vaccine was targetted to kill people.

Speaking to a crowd of people, the Kogi State governor expressed his doubt about the efficacy of the vaccine noting that the speed with which it was rushed out ahead of remedies for other diseases including HIV, headaches, malaria, cancer, and such was suspicious.

GWG had reported several mobilization drives for Mr Bello, whose supporters are urging him to vie for the presidential election in 2023.

The governor has been pushing a conspiracy theory about COVID-19 since last year and had attempted to put some officials of the Nigeria Centre for Disease Control, NCDC who visited the state on advocacy in quarantine.

In a viral video in which he condemned the use of the COVID-19 vaccine, Bello while expressing his reservations on the vaccine said just like the pfizer vaccine tried in Kano in the past that this COVID-19 vaccine could be targetted to kill.

“Vaccines are being produced in less than one year of COVID-19. There is no vaccine yet for HIV, malaria, cancer, headache and for several other diseases that are killing us. They want to use the (COVID-19) vaccines to introduce the disease that will kill you and us. God forbid,” he said.

“We should draw our minds back to what happened in Kano during the Pfizer polio vaccines that crippled and killed our children. We have learned our lessons.

“If they say they are taking the vaccines in the public allow them take their vaccines. Don’t say I said you should not take it but if you want to take it open your eyes before you take the vaccines.”

The governor had similarly in his New Year message to the people said that the state would not respond to the second wave of the COVID-19 pandemic.

Send Us A Press Statement Advertise With Us Contact Us

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *